[Recommendations for the treatment of premature ejaculation].

Recommandations pour le traitement de l’éjaculation prématurée.
Dapoxetine Dapoxétine Médecine sexuelle Premature ejaculation Sexologie Sexology Sexual medicine Éjaculation précoce

Journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
ISSN: 1166-7087
Titre abrégé: Prog Urol
Pays: France
ID NLM: 9307844

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 04 01 2023
accepted: 10 02 2023
medline: 4 4 2023
pubmed: 4 3 2023
entrez: 3 3 2023
Statut: ppublish

Résumé

The Post-University Interdisciplinary Association of Sexology (AIUS) has brought together a panel of experts to develop French recommendations for the management of premature ejaculation. Systematic review of the literature between 01/1995 and 02/2022. Use of the clinical practice guidelines (CPR) method. We recommend giving all patients with PE psychosexological counseling, and whenever possible combining pharmacotherapies and sexually-focused cognitive-behavioral therapies, involving the partner in the treatment process. Other sexological approaches could be useful. We recommend the use of dapoxetine as first-line, on-demand oral therapy for primary and acquired PE. We recommend the use of lidocaine 150mg/mL/prilocaine 50mg/mL spray as local treatment for primary PE. We suggest the combination of dapoxetine and lidocaine/prilocaine in patients insufficiently improved by monotherapy. In patients who have not responded to treatments with marketing authorisation, we suggest using an off-label SSRI, preferably paroxetine, in the absence of a contraindication. We recommend treating ED before PE in patients with both symptoms. We do not recommend using α-1 blockers or tramadol in patients with PE. We do not recommend routine posthectomy or penile frenulum surgery for PE. These recommendations should contribute to improving the management of PE.

Identifiants

pubmed: 36868935
pii: S1166-7087(23)00045-3
doi: 10.1016/j.purol.2023.02.003
pii:
doi:

Substances chimiques

dapoxetine GB2433A4M3
Benzylamines 0
Lidocaine, Prilocaine Drug Combination 0

Types de publication

Review English Abstract Practice Guideline

Langues

fre

Sous-ensembles de citation

IM

Pagination

237-246

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Auteurs

E Huyghe (E)

Médecine de la reproduction, CHU de Toulouse, site de Paule-de-Viguier, Toulouse, France; Département d'urologie, transplantation rénale et andrologie, CHU de Toulouse, hôpital Rangueil, Toulouse, France; UMR DEFE Inserm 1203, université de Toulouse III, université de Montpellier, Montpellier, France. Electronic address: eric.huyghe@yahoo.fr.

B Cuzin (B)

Service d'urologie, chirurgie de la transplantation, CHU de Lyon, hôpital Édouard-Herriot, Lyon, France; Service de médecine de la reproduction, hôpital Femme-Mère-Enfant, HCL, Bron, France.

L Grellet (L)

Cabinet de sexologie, 19, bis rue Magnol, 34000 Montpellier, France.

A Faix (A)

Cabinet d'urologie, 265, avenue des États du Languedoc, Montpellier, France.

T Almont (T)

Service d'oncologie, CHU de Martinique, Fort-de-France, France.

C Burte (C)

Cabinet de médecine sexuelle, 4, rue des États-Unis, Cannes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH